Effect of first-line endocrine therapy in patients with hormone-sensitive advanced breast cancer: a network meta-analysis [Corrigendum]
Zhang T, Feng F, Zhao W, et al. Onco Targets Ther. 2018;11:2647–2656.
On page 2647, affiliation list, affiliation 1 for authors Tingting Zhang and Chuanxin Zang should be:
College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China
Read the original article.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]